CLIA-certified and CAP-accredited Testing Facilities

At Interpace Biosciences, we are committed to providing unparalleled service for each doctor, patient, pharmaceutical and biotechnology customer served.

Molecular testing at Interpace Diagnostics is performed in our high-tech laboratories led by pioneers in molecular diagnostics. We have two laboratories, one located in Pittsburgh, Pennsylvania and the other in New Haven, Connecticut, both of which have Clinical Laboratory Improvement Amendment (CLIA) certification and College of American Pathologists (CAP) accreditation. Our Pennsylvania laboratory currently houses one of the largest repositories of pancreatic cyst samples that have undergone the rigors of molecular testing.

Our state-of-the-art laboratories at Interpace Pharma Solutions, located in Research Triangle Park (RTP), North Carolina and Rutherford, New Jersey, also adhere to the highest levels of regulatory standards in order to ensure the highest quality results. In addition to also being CLIA-certified and CAP-accredited, the Interpace Pharma Solutions clinical laboratories are HIPAA-compliant and hold licensure in several US states. 

Click below for more information about the licensure and quality assurance programs for each of our locations.